News & Updates
Filter by Specialty:
Add-on cannabidiol induces sustained seizure reduction in treatment-resistant epilepsy
27 Jan 2023
Patients with treatment-resistant epilepsy appear to benefit from add-on cannabidiol, which a recent study has shown to help reduce seizure frequency for up to 192 weeks.
Add-on cannabidiol induces sustained seizure reduction in treatment-resistant epilepsy
27 Jan 2023
Pain, discomfort persist in JIA patients despite medication use
18 Jan 2023
Problems with pain or discomfort continue to bother young adults with juvenile idiopathic arthritis (JIA) despite their constant use of medication, a study has shown.
Pain, discomfort persist in JIA patients despite medication use
18 Jan 2023
Lebrikizumab–topical corticosteroid combo improves outcomes in moderate-to-severe AD
16 Jan 2023
byJairia Dela Cruz
Treatment with lebrikizumab, when combined with low- to mid-potency topical corticosteroid (TCS), helps reduce disease severity in adolescent and adult patients with moderate-to-severe atopic dermatitis (AD), with a safety profile consistent with that reported in previous AD studies, according to the phase III ADhere trial.